LIVN

LivaNova PLC

LIVN, USA

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

https://www.livanova.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
LIVN
stock
LIVN

Analyzing LivaNova (NASDAQ:LIVN) & Sintx Technologies (NASDAQ:SINT) Defense World

Read more →
LIVN
stock
LIVN

LivaNova stock hits 52-week high at 64.46 USD Investing.com India

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$69.1

Analyst Picks

Strong Buy

4

Buy

4

Hold

3

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

3.01

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

2.32 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.05 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

17.38 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.21

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 93.36% of the total shares of LivaNova PLC

1.

BlackRock Inc

(13.3796%)

since

2025/06/30

2.

PRIMECAP Management Company

(8.5005%)

since

2025/06/30

3.

Vanguard Group Inc

(4.4961%)

since

2025/06/30

4.

Millennium Management LLC

(4.4427%)

since

2025/06/30

5.

State Street Corp

(3.8123%)

since

2025/06/30

6.

AQR Capital Management LLC

(3.7542%)

since

2025/06/30

7.

Vanguard Capital Opportunity Inv

(3.6109%)

since

2025/06/30

8.

iShares Core S&P Mid-Cap ETF

(3.2505%)

since

2025/08/31

9.

Dimensional Fund Advisors, Inc.

(2.9565%)

since

2025/06/30

10.

Geode Capital Management, LLC

(2.6185%)

since

2025/06/30

11.

iShares Russell 2000 ETF

(2.4169%)

since

2025/08/31

12.

Wellington Management Company LLP

(2.3409%)

since

2025/06/30

13.

Artisan Partners Limited Partnership

(2.285%)

since

2025/06/30

14.

Hotchkis & Wiley Capital Management LLC

(2.123%)

since

2025/06/30

15.

Goldman Sachs Group Inc

(2.0098%)

since

2025/06/30

16.

Amvescap Plc.

(1.8841%)

since

2025/06/30

17.

Redmile Group, LLC

(1.7111%)

since

2025/06/30

18.

Victory Capital Management Inc.

(1.6836%)

since

2025/06/30

19.

Invesco Small Cap Value A

(1.648%)

since

2025/07/31

20.

PRIMECAP Odyssey Aggressive Growth

(1.6244%)

since

2025/06/30

21.

D. E. Shaw & Co LP

(1.5905%)

since

2025/06/30

22.

Artisan Non-U.S. Small-Mid Growth Comp

(1.5174%)

since

2025/06/30

23.

Artisan International Small-Mid Investor

(1.5174%)

since

2025/06/30

24.

ExodusPoint Capital Management, LP

(1.4922%)

since

2025/06/30

25.

Marshall Wace Asset Management Ltd

(1.4921%)

since

2025/06/30

26.

Scopia Management Inc

(1.4913%)

since

2025/06/30

27.

Nuveen, LLC

(1.4492%)

since

2025/06/30

28.

Vanguard PRIMECAP Core Inv

(1.1853%)

since

2025/06/30

29.

Fort Washington Small Company Equity

(1.1064%)

since

2025/06/30

30.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0712%)

since

2025/07/31

31.

Fidelity Small Cap Index

(1.0014%)

since

2025/06/30

32.

PRIMECAP Odyssey Growth

(0.9751%)

since

2025/06/30

33.

Small Company Equity - FTWA

(0.954%)

since

2025/03/31

34.

Touchstone Small Company A

(0.944%)

since

2025/06/30

35.

Bestinfond FI

(0.9004%)

since

2025/06/30

36.

BlackRock Global Equity Mkt Netrl Instl

(0.891%)

since

2025/07/31

37.

iShares Russell 2000 Value ETF

(0.8797%)

since

2025/08/31

38.

Bestinver Internacional FI

(0.8622%)

since

2025/06/30

39.

SPDR® S&P MIDCAP 400 ETF Trust

(0.765%)

since

2025/07/31

40.

Vanguard Strategic Equity Inv

(0.7295%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.8116

Latest Release

Date

2025-09-30

EPS Actual

1.11

EPS Estimate

0.92

EPS Difference

0.19

Surprise Percent

20.6522%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5.5)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.